Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 60 peer-reviewed journal articles Updated
Pathology

Understanding Cutaneous Small Vessel Vasculitis

At a Glance

Cutaneous small vessel vasculitis (CSVV) is an inflammation of the skin's smallest blood vessels, causing a raised purple rash. It is often triggered by an infection or medication. In most cases, it is mild, affects only the skin, and resolves on its own within 3 to 4 weeks.

Cutaneous Small Vessel Vasculitis (CSVV) is an inflammation of the smallest blood vessels in your skin [1][2]. While the appearance of the rash can be quite alarming—often presenting as dark red or purple spots that you can feel with your fingers (palpable purpura)—the condition is frequently mild and tends to go away on its own [3][4][5].

In many cases, this is a “single-organ” condition, meaning the inflammation is strictly limited to the skin and does not affect your internal organs [6][7].

Understanding the Names

You may hear your medical team use several different terms to describe your condition. These names are often used interchangeably, although they describe the disease from different perspectives:

  • Cutaneous Small Vessel Vasculitis (CSVV): The clinical name for inflammation of the small vessels in the skin [4].
  • Leukocytoclastic Vasculitis (LCV): This is a term used by pathologists looking at your skin under a microscope [2]. It refers to the way white blood cells break apart (leukocytoclasia) while attacking the blood vessels [2][8].
  • Hypersensitivity Vasculitis: An older term sometimes used when the rash is thought to be an “allergic-like” reaction to a trigger like a medication or infection [9][10].

How CSVV Happens

The condition is caused by a “traffic jam” in your immune system. It follows a specific biological sequence:

  1. Immune Complex Formation: When your body reacts to a trigger (like a virus or a drug), it creates immune complexes—clusters of antibodies and proteins [1][2].
  2. The “Stuck” Clusters: These clusters travel through the bloodstream and get stuck in the walls of the small blood vessels in your skin [1][11].
  3. The Inflammatory Response: Once stuck, these clusters activate the complement system, a part of your immune system that acts like a chemical alarm [12][11].
  4. Neutrophil Damage: White blood cells called neutrophils rush to the area to “clean up” the clusters [2][13]. In the process, they release enzymes that accidentally damage the blood vessel walls, causing blood to leak into the surrounding skin—creating the purple spots you see [2][12].

Reassuring Facts for the Newly Diagnosed

While the rash can look aggressive, there are several stabilizing facts to keep in mind:

01

Symptoms and Triggers: Why It Happens and What to Watch For

Learn the symptoms of cutaneous small vessel vasculitis (CSVV), including palpable purpura. Discover common medication triggers and when to seek urgent care.

02

The Diagnostic Journey: Biopsies and Bloodwork

Learn how Cutaneous Small Vessel Vasculitis (CSVV) is diagnosed. Understand the importance of H&E and DIF skin biopsies, plus key lab tests like urinalysis.

What to Expect and Healing Timeline

For a first-time diagnosis, the general outlook (prognosis) is very good [3]. Most cases are “self-limiting,” meaning they resolve on their own once the trigger is gone [3][16]. As you heal, the purple spots typically fade over 3 to 4 weeks. They will often transition into a brownish color, similar to a healing bruise, before disappearing completely [3].

While a small number of people may experience the rash again (recurrent) or have it last longer (chronic), your care team will use blood tests and urinalysis to monitor your health and determine if additional treatment is needed [3][4].

Explore the rest of this guide to learn more about Treating the Skin and Building Your Care Team.

Common questions in this guide

What is cutaneous small vessel vasculitis (CSVV)?
CSVV is an inflammation of the smallest blood vessels in your skin. It usually presents as a rash of dark red or purple spots, known as palpable purpura, that you can actually feel with your fingers.
What causes a CSVV skin rash?
The rash is caused by your immune system reacting to a trigger, such as a recent viral infection or a new medication. This reaction creates immune clusters that get stuck in your skin's blood vessels, leading to inflammation and minor blood leakage.
Is leukocytoclastic vasculitis the same as CSVV?
Yes, leukocytoclastic vasculitis (LCV) is another name for CSVV. LCV is simply the term that pathologists use to describe how the breaking-apart white blood cells look under a microscope.
How long does it take for CSVV to heal?
For a first-time diagnosis, CSVV typically resolves on its own once the trigger is removed. The purple spots usually fade over 3 to 4 weeks, often turning a brownish color like a healing bruise before disappearing completely.
Does CSVV affect my kidneys or internal organs?
In many cases, CSVV is limited entirely to the skin and does not affect your internal organs. However, your care team will likely use blood and urine tests to confirm that your kidneys and other vital organs are healthy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my vasculitis limited only to my skin, or have you found any evidence of systemic involvement in my kidneys or other organs?
  2. 2.Which name for this condition applies best to my case: CSVV, LCV, or hypersensitivity vasculitis?
  3. 3.Based on the 2024 International Consensus Statement, what is the recommended management algorithm for my specific situation?
  4. 4.Do you suspect a specific trigger, such as my recent infection or a medication I am taking?
  5. 5.Should I have follow-up urinalysis or blood work to monitor my kidney function over the next few weeks?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination.

    Fiorillo G, Pancetti S, Cortese A, et al.

    Journal of autoimmunity 2022; (127()):102783 doi:10.1016/j.jaut.2021.102783.

    PMID: 34973526
  2. 2

    Diagnosis and management of leukocytoclastic vasculitis.

    Fraticelli P, Benfaremo D, Gabrielli A

    Internal and emergency medicine 2021; (16(4)):831-841 doi:10.1007/s11739-021-02688-x.

    PMID: 33713282
  3. 3

    Leukocytoclastic Vasculitis Masquerading as Chronic Idiopathic Thrombocytopenic Purpura.

    Tasnim S, Yousuf H, Al-Hilli Y, et al.

    Federal practitioner : for the health care professionals of the VA, DoD, and PHS 2022; (39(11)):e0337 doi:10.12788/fp.0337.

    PMID: 36582494
  4. 4

    Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force.

    Alpsoy E, Caproni M, Wetter DA, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(6)):946-962 doi:10.1111/jdv.70249.

    PMID: 41399325
  5. 5

    Warfarin induced leukocytoclastic vasculitis: an extraordinary side effect.

    Elantably D, Mourad A, Elantably A, Effat M

    Journal of thrombosis and thrombolysis 2020; (49(1)):149-152 doi:10.1007/s11239-019-01924-8.

    PMID: 31375992
  6. 6

    Clinical study on single-organ cutaneous small vessels vasculitis (SoCSVV).

    Pastuszczak M, Celińska-Löwenhoff M, Sułowicz J, et al.

    Medicine 2017; (96(12)):e6376 doi:10.1097/MD.0000000000006376.

    PMID: 28328827
  7. 7

    Management of cutaneous vasculitis.

    Micheletti RG, Pagnoux C

    Presse medicale (Paris, France : 1983) 2020; (49(3)):104033 doi:10.1016/j.lpm.2020.104033.

    PMID: 32645416
  8. 8

    Anti-C1q antibodies in IgG4-related disease are common and associated with renal involvement and cutaneous small-vessel vasculitis.

    Martín-Nares E, Nuñez-Álvarez CA, Hernández-Molina G

    Rheumatology (Oxford, England) 2025; (64(6)):3701-3709 doi:10.1093/rheumatology/keaf020.

    PMID: 39798124
  9. 9

    Comparison of clinical and laboratory data of adult patients with cutaneous IgA vasculitis and non-IgA vasculitis.

    Gambichler T, Bui D, Domin B, et al.

    Clinical and experimental dermatology 2024; (49(8)):859-865 doi:10.1093/ced/llae062.

    PMID: 38446988
  10. 10

    Outline of guidelines for the management of vasculitis and vascular disorders in Japan, 2016 revised edition.

    Ikeda T, Furukawa F, Kawakami T, et al.

    The Journal of dermatology 2018; (45(2)):122-127 doi:10.1111/1346-8138.14086.

    PMID: 28983940
  11. 11

    Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall.

    Takatu CM, Heringer APR, Aoki V, et al.

    Immunologic research 2017; (65(1)):395-401 doi:10.1007/s12026-016-8850-6.

    PMID: 27530606
  12. 12

    Segmental cutaneous leukocytoclastic vasculitis associated with herpes zoster: a case report and literature review.

    Furuoka K, Fukumoto T, Masuda Y, et al.

    Dermatology reports 2023; (15(4)):9709 doi:10.4081/dr.2023.9709.

    PMID: 38327588
  13. 13

    A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed COVID-19 Vaccine-Related Dermatologic Manifestations.

    Salehi S, Sadeghi S, Kalantari Y, Goodarzi A

    The American Journal of dermatopathology 2023; (45(1)):1-27 doi:10.1097/DAD.0000000000002320.

    PMID: 36484603
  14. 14

    Cutaneous leukocytoclastic vasculitis leading to extensive digital necrosis as the only COVID-19 clinical manifestation.

    Pouy R, Bermejo M, Durlach A, Bani-Sadr F

    Vascular diseases (Paris, France) 2026; (51(2)):97-99 doi:10.1016/j.vasdi.2025.12.003.

    PMID: 41577611
  15. 15

    Cutaneous necrotizing small-vessel vasculitis induced by acute hepatitis E.

    Viallard JF, Vergier B, Lazaro E, et al.

    Clinical case reports 2019; (7(8)):1539-1541 doi:10.1002/ccr3.2167.

    PMID: 31428384
  16. 16

    Successful Treatment of Cutaneous Small Vessel Vasculitis With Leflunomide.

    Stiegler JD, Sami N

    JAMA dermatology 2017; (153(9)):940-942 doi:10.1001/jamadermatol.2017.1316.

    PMID: 28614577

This page provides educational information about cutaneous small vessel vasculitis. Always consult your healthcare provider for an accurate diagnosis and to ensure your internal organs are not affected.

Get notified when new evidence is published on Cutaneous small vessel vasculitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.